This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. PT Phapros Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was Rp1144.401. PT Phapros Tbk's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is Rp0.00.
As of today (2026-06-30), PT Phapros Tbk's share price is Rp248.00. PT Phapros Tbk's Median PS Value is Rp0.00. Therefore, PT Phapros Tbk's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for PT Phapros Tbk's Median PS Value or its related term are showing as below:
ISX:PEHA's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.84 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
PT Phapros Tbk (ISX:PEHA) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
PT Phapros Tbk's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
248.00
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Phapros Tbk Median PS Value Related Terms
PT Phapros Tbk Median PS Value Historical Data
* Premium members only.
The historical data trend for PT Phapros Tbk's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PEHA vs ZTS, UTHR, VTRS: Median PS Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Phapros Tbk's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Phapros Tbk Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Phapros Tbk's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where PT Phapros Tbk's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
PT Phapros Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp1144.401.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Phapros Tbk (ISX:PEHA) has a Median PS Value of Rp0.00 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PT Phapros Tbk and its competitors. According to the industry distribution chart, PT Phapros Tbk ranks #999999 out of 544 companies in the Drug Manufacturers industry.
Is PT Phapros Tbk's Median PS Value too high?
PT Phapros Tbk's current Median PS Value is Rp0.00. Based on the distribution chart, PT Phapros Tbk ranks #999999 out of 544 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PT Phapros Tbk has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Phapros Tbk's Median PS Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Phapros Tbk ranks #999999 out of 544 companies for Median PS Value. This places PT Phapros Tbk in the lower half of its industry. The industry median Median PS Value is 0.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.84, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PT Phapros Tbk and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Phapros Tbk's current Median PS Value is Rp0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Phapros Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Phapros Tbk (ISX:PEHA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp385.70, compared to a current price of Rp248.00 — trading 35.7% below its estimated fair value. The current Median PS Value is Rp0.00. PT Phapros Tbk's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For PT Phapros Tbk (ISX:PEHA), the current Median PS Value is Rp0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Phapros Tbk (ISX:PEHA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Phapros Tbk stock appears to be undervalued.
The current stock price of Rp248.00 is trading 35.7% below its estimated GF Value™ of Rp385.70.
GuruFocus considers PT Phapros Tbk to be Possible Value Trap.
Key valuation signals for ISX:PEHA:
Median PS Value: Rp0.00
GF Value™: Rp385.70 vs. price of Rp248.00 (35.7% below fair value)
No single metric tells the full story. See the ISX:PEHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
74GF Score
Get the complete analysis for ISX:PEHA
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PEHA has been successfully added to your 
